Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kapil Gadkar

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|December 14, 2025
A Generalized Minimal PBPK-PD Model of Bispecific Antibodies: Case Studies and Applications in Drug DevelopmentPhillip Spinosa, Louis Joslyn, Saroja Ramanujan, et al.
Journal of Lipid Research|November 3, 2015
Evaluation of HDL-modulating interventions for cardiovascular risk reduction using a systems pharmacology approachKapil Gadkar, James Lu, Srikumar Sahasranaman, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 21, 2020
gQSPSim: A SimBiology-Based GUI for Standardized QSP Model Development and ApplicationIraj Hosseini, Justin Feigelman, Anita Gajjala, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 6, 2018
gPKPDSim: a SimBiology<sup>®</sup>-based GUI application for PKPD modeling in drug developmentIraj Hosseini, Anita Gajjala, Daniela Bumbaca Yadav, et al.
NPJ Systems Biology and Applications|August 30, 2020
Mitigating the risk of cytokine release syndrome in a Phase I trial of CD20/CD3 bispecific antibody mosunetuzumab in NHL: impact of translational system modelingIraj Hosseini, Kapil Gadkar, Eric Stefanich, et al.
Molecular Pharmaceutics|June 21, 2017
Ocular Pharmacokinetics of Therapeutic Antibodies Given by Intravitreal Injection: Estimation of Retinal Permeabilities Using a 3-Compartment Semi-Mechanistic ModelLaurence A Hutton-Smith, Eamonn A Gaffney, Helen M Byrne, et al.
Genome Research|September 3, 2004
A benchmark for methods in reverse engineering and model discrimination: problem formulation and solutionsAndreas Kremling, Sophia Fischer, Kapil Gadkar, et al.
NPJ Systems Biology and Applications|June 27, 2017
Clinical responses to ERK inhibition in <i>BRAF</i><sup>V600E</sup>-mutant colorectal cancer predicted using a computational modelDaniel C Kirouac, Gabriele Schaefer, Jocelyn Chan, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 1, 2021
Quantitative systems pharmacology model-based investigation of adverse gastrointestinal events associated with prolonged treatment with PI3-kinase inhibitorsKapil Gadkar, Christina Friedrich, Vincent Hurez, et al.
NPJ Systems Biology and Applications|September 8, 2017
Erratum: Clinical responses to ERK inhibition in <i>BRAF</i><sup>V600E</sup>-mutant colorectal cancer predicted using a computational modelDaniel C Kirouac, Gabriele Schaefer, Jocelyn Chan, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
CPT: Pharmacometrics & Systems Pharmacology|December 14, 2025
A Generalized Minimal PBPK-PD Model of Bispecific Antibodies: Case Studies and Applications in Drug DevelopmentPhillip Spinosa, Louis Joslyn, Saroja Ramanujan, et al.
Journal of Lipid Research|November 3, 2015
Evaluation of HDL-modulating interventions for cardiovascular risk reduction using a systems pharmacology approachKapil Gadkar, James Lu, Srikumar Sahasranaman, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 21, 2020
gQSPSim: A SimBiology-Based GUI for Standardized QSP Model Development and ApplicationIraj Hosseini, Justin Feigelman, Anita Gajjala, et al.
Journal of Pharmacokinetics and Pharmacodynamics|January 6, 2018
gPKPDSim: a SimBiology<sup>®</sup>-based GUI application for PKPD modeling in drug developmentIraj Hosseini, Anita Gajjala, Daniela Bumbaca Yadav, et al.
NPJ Systems Biology and Applications|August 30, 2020
Mitigating the risk of cytokine release syndrome in a Phase I trial of CD20/CD3 bispecific antibody mosunetuzumab in NHL: impact of translational system modelingIraj Hosseini, Kapil Gadkar, Eric Stefanich, et al.
Molecular Pharmaceutics|June 21, 2017
Ocular Pharmacokinetics of Therapeutic Antibodies Given by Intravitreal Injection: Estimation of Retinal Permeabilities Using a 3-Compartment Semi-Mechanistic ModelLaurence A Hutton-Smith, Eamonn A Gaffney, Helen M Byrne, et al.
Genome Research|September 3, 2004
A benchmark for methods in reverse engineering and model discrimination: problem formulation and solutionsAndreas Kremling, Sophia Fischer, Kapil Gadkar, et al.
NPJ Systems Biology and Applications|June 27, 2017
Clinical responses to ERK inhibition in <i>BRAF</i><sup>V600E</sup>-mutant colorectal cancer predicted using a computational modelDaniel C Kirouac, Gabriele Schaefer, Jocelyn Chan, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 1, 2021
Quantitative systems pharmacology model-based investigation of adverse gastrointestinal events associated with prolonged treatment with PI3-kinase inhibitorsKapil Gadkar, Christina Friedrich, Vincent Hurez, et al.
NPJ Systems Biology and Applications|September 8, 2017
Erratum: Clinical responses to ERK inhibition in <i>BRAF</i><sup>V600E</sup>-mutant colorectal cancer predicted using a computational modelDaniel C Kirouac, Gabriele Schaefer, Jocelyn Chan, et al.
Pageof 3